The multiple faces of autoimmune Addison's disease in children

被引:0
|
作者
Capalbo, Donatella [1 ]
Esposito, Andrea [2 ]
Gaeta, Valeria [1 ]
Lorello, Paola [1 ]
Vasaturo, Sara [1 ]
Di Mase, Raffaella [3 ]
Salerno, Mariacarolina [1 ]
机构
[1] Univ Naples Federico II, Dept Translat Med Sci, Pediat Endocrinol Unit, Naples, Italy
[2] Santobono Pausilipon Childrens Hosp, Dept Emergency, Naples, Italy
[3] Univ Hosp Federico II, Dept Mother & Child, Pediat Endocrinol Unit, Naples, Italy
来源
关键词
primary adrenal insufficiency; autoimmune Addison's disease; autoimmune polyendocrine syndromes; pediatric age; adrenal crises; PRIMARY ADRENAL INSUFFICIENCY; CANDIDIASIS-ECTODERMAL DYSTROPHY; POLYGLANDULAR SYNDROME TYPE-2; AUTOANTIBODIES; DIAGNOSIS; HYPONATREMIA; MECHANISMS; UPDATE;
D O I
10.3389/fendo.2024.1411774
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary adrenal insufficiency (PAI) is a rare medical condition, characterized by a deficiency in adrenal hormones. Although rare, PAI is a life-threatening disease requiring prompt recognition and treatment. However, symptoms of PAI are often non-specific and diagnosis can be challenging, causing frequent diagnostic delays. In adults, autoimmunity is the most common cause of PAI in industrialized countries, whereas in children, the most frequent etiology is represented by congenital defects of steroidogenesis and, in particular, by congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. A few recent case series from different countries have reported that autoimmunity is the second most common etiology of PAI in the pediatric age group. However, data on autoimmune PAI in children are still scant and the exact epidemiology, clinical manifestations, and long-term outcomes of this condition have yet to be defined. The scope of this review is to summarize the current knowledge on the etiology, presentation, and treatment of autoimmune PAI in childhood and to increase physicians' awareness of the signs that should raise an early suspicion of this condition.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Clues for early detection of autoimmune Addison's disease - myths and realities
    Saevik, A. B.
    Akerman, A. -K.
    Gronning, K.
    Nermoen, I.
    Valland, S. F.
    Finnes, T. E.
    Isaksson, M.
    Dahlqvist, P.
    Bergthorsdottir, R.
    Ekwall, O.
    Skov, J.
    Nedrebo, B. G.
    Hulting, A. -L.
    Wahlberg, J.
    Svartberg, J.
    Hoybye, C.
    Bleskestad, I. H.
    Jorgensen, A. P.
    Kampe, O.
    Oksnes, M.
    Bensing, S.
    Husebye, E. S.
    JOURNAL OF INTERNAL MEDICINE, 2018, 283 (02) : 190 - 199
  • [32] Chromogranin A as a useful neuroendocrine marker in patients with autoimmune Addison's disease
    El Ali, Z.
    Fichna, M.
    Piniewska, J.
    Kosowicz, J.
    Grzymislawski, M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2010, 33 (03) : 186 - 191
  • [33] Screening for associated autoimmune disorders in Polish patients with Addison’s disease
    Marta Fichna
    Piotr Fichna
    Maria Gryczyńska
    Jarosław Walkowiak
    Magdalena Żurawek
    Jerzy Sowiński
    Endocrine, 2010, 37 : 349 - 360
  • [34] Impact of Month of Birth on the Risk of Development of Autoimmune Addison's Disease
    Pazderska, Agnieszka
    Fichna, Marta
    Mitchell, Anna L.
    Napier, Catherine M.
    Gan, Earn
    Ruchala, Marek
    Santibanez-Koref, Mauro
    Pearce, Simon H.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (11): : 4214 - 4218
  • [35] CTLA-4 as a genetic determinant in autoimmune Addison’s disease
    A S B Wolff
    A L Mitchell
    H J Cordell
    A Short
    B Skinningsrud
    W Ollier
    K Badenhoop
    G Meyer
    A Falorni
    O Kampe
    D Undlien
    S H S Pearce
    E S Husebye
    Genes & Immunity, 2015, 16 : 430 - 436
  • [36] Screening for associated autoimmune disorders in Polish patients with Addison's disease
    Fichna, Marta
    Fichna, Piotr
    Gryczynska, Maria
    Walkowiak, Jarosaw
    Zurawek, Magdalena
    Sowinski, Jerzy
    ENDOCRINE, 2010, 37 (02) : 349 - 360
  • [37] Polyglandular autoimmune syndrome type II with diabetes and Addison's disease
    Arndt, S
    Schacht, P
    Bergt, S
    Reinmuth, J
    Millahn, K
    Keysser, M
    INTERNIST, 2002, 43 (03): : 410 - 413
  • [38] CTLA-4 as a genetic determinant in autoimmune Addison's disease
    Wolff, A. S. B.
    Mitchell, A. L.
    Cordell, H. J.
    Short, A.
    Skinningsrud, B.
    Ollier, W.
    Badenhoop, K.
    Meyer, G.
    Falorni, A.
    Kampe, O.
    Undlien, D.
    Pearce, S. H. S.
    Husebye, E. S.
    GENES AND IMMUNITY, 2015, 16 (06) : 430 - 436
  • [39] Partial recovery of adrenal function in a patient with autoimmune Addison’s disease
    L. C. C. J. Smans
    P. M. J. Zelissen
    Journal of Endocrinological Investigation, 2008, 31 : 672 - 674
  • [40] Chromogranin A as a useful neuroendocrine marker in patients with autoimmune Addison’s disease
    Z. El Ali
    M. Fichna
    J. Piniewska
    J. Kosowicz
    M. Grzymisławski
    Journal of Endocrinological Investigation, 2010, 33 : 186 - 191